JP2024519626A5 - - Google Patents

Info

Publication number
JP2024519626A5
JP2024519626A5 JP2022573567A JP2022573567A JP2024519626A5 JP 2024519626 A5 JP2024519626 A5 JP 2024519626A5 JP 2022573567 A JP2022573567 A JP 2022573567A JP 2022573567 A JP2022573567 A JP 2022573567A JP 2024519626 A5 JP2024519626 A5 JP 2024519626A5
Authority
JP
Japan
Prior art keywords
pyrimidine
amine
phenyl
isoxazolidine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022573567A
Other languages
English (en)
Japanese (ja)
Other versions
JP7896880B2 (ja
JP2024519626A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/KR2022/006994 external-priority patent/WO2022245085A1/ko
Publication of JP2024519626A publication Critical patent/JP2024519626A/ja
Publication of JP2024519626A5 publication Critical patent/JP2024519626A5/ja
Application granted granted Critical
Publication of JP7896880B2 publication Critical patent/JP7896880B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022573567A 2021-05-17 2022-05-16 ヘテロアリール誘導体化合物およびその用途{Heteroaryl derivative compounds,and uses thereof} Active JP7896880B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR20210063733 2021-05-17
KR10-2021-0063733 2021-05-17
PCT/KR2022/006994 WO2022245085A1 (ko) 2021-05-17 2022-05-16 헤테로아릴 유도체 화합물 및 이의 용도

Publications (3)

Publication Number Publication Date
JP2024519626A JP2024519626A (ja) 2024-05-21
JP2024519626A5 true JP2024519626A5 (cg-RX-API-DMAC7.html) 2025-03-25
JP7896880B2 JP7896880B2 (ja) 2026-07-29

Family

ID=84141801

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022573567A Active JP7896880B2 (ja) 2021-05-17 2022-05-16 ヘテロアリール誘導体化合物およびその用途{Heteroaryl derivative compounds,and uses thereof}

Country Status (12)

Country Link
US (3) US12037330B2 (cg-RX-API-DMAC7.html)
EP (1) EP4342895A4 (cg-RX-API-DMAC7.html)
JP (1) JP7896880B2 (cg-RX-API-DMAC7.html)
KR (2) KR102607051B1 (cg-RX-API-DMAC7.html)
CN (1) CN115667251A (cg-RX-API-DMAC7.html)
AU (1) AU2022271388A1 (cg-RX-API-DMAC7.html)
BR (1) BR112022024068A2 (cg-RX-API-DMAC7.html)
CA (1) CA3180295A1 (cg-RX-API-DMAC7.html)
IL (1) IL298474A (cg-RX-API-DMAC7.html)
MX (1) MX2022014887A (cg-RX-API-DMAC7.html)
TW (1) TWI869674B (cg-RX-API-DMAC7.html)
WO (1) WO2022245085A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202309022A (zh) 2021-04-13 2023-03-01 美商努法倫特公司 用於治療具egfr突變之癌症之胺基取代雜環
CN115667251A (zh) * 2021-05-17 2023-01-31 株式会社沃若诺伊生物 杂芳基衍生物化合物、及其用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL161662A0 (en) 2001-11-01 2004-09-27 Janssen Pharmaceutica Nv Heteroaryl amines as glycogen synthase kinase 3 beta inhibitors (gsk3 inhibitors)
GB0215844D0 (en) 2002-07-09 2002-08-14 Novartis Ag Organic compounds
GB0512324D0 (en) 2005-06-16 2005-07-27 Novartis Ag Organic compounds
TWI389893B (zh) 2007-07-06 2013-03-21 Astellas Pharma Inc 二(芳胺基)芳基化合物
KR101247840B1 (ko) 2008-02-22 2013-03-26 에프. 호프만-라 로슈 아게 아밀로이드 베타 조절제
EP3205650B1 (en) 2014-10-11 2021-08-04 Shanghai Hansoh Biomedical Co., Ltd. Egfr inhibitor, and preparation and application thereof
EP3929190B1 (en) 2014-10-13 2024-12-25 Yuhan Corporation Compounds and compositions for modulating egfr mutant kinase activities
JP2020526499A (ja) 2017-07-05 2020-08-31 シーエス ファーマテック リミテッド Egfrチロシンキナーゼの臨床上重要な突然変異体の選択的阻害剤
US11440899B2 (en) 2017-10-17 2022-09-13 Merck Patent Gmbh Pyrimidine TBK/IKKe inhibitor compounds and uses thereof
JP7109013B2 (ja) 2019-03-19 2022-07-29 ボロノイ インコーポレイテッド ヘテロアリール誘導体、ヘテロアリール誘導体の生成方法、およびヘテロアリール誘導体を有効成分として含む医薬組成物
WO2020235902A1 (ko) * 2019-05-17 2020-11-26 주식회사 보로노이 헤테로고리 융합 피리미딘 유도체 및 이의 용도
KR20210032093A (ko) 2019-09-16 2021-03-24 제이투에이치바이오텍 (주) Egfr 돌연변이 키나제 성장 억제 효과를 나타내는 피리미딘 유도체 및 이의 의약 용도
US20230322753A1 (en) 2020-09-18 2023-10-12 Voronoi Inc. Heteroaryl derivative, method for preparation thereof, and pharmaceutical composition comprising same as active ingredient
KR20220085735A (ko) 2020-12-14 2022-06-22 보로노이바이오 주식회사 아이소옥사졸리딘 유도체 화합물 및 이의 용도
US20240262815A1 (en) 2021-05-07 2024-08-08 Voronoi Inc. Heteroaryl derivative, method for preparing same, and pharmaceutical composition comprising same as active ingredient
CN115667251A (zh) * 2021-05-17 2023-01-31 株式会社沃若诺伊生物 杂芳基衍生物化合物、及其用途

Similar Documents

Publication Publication Date Title
CN112079830B (zh) 含并环类衍生物抑制剂、其制备方法和应用
CN113874363B (zh) 蛋白质酪氨酸磷酸酶抑制剂
CN112368283B (zh) 含二并环类衍生物抑制剂、其制备方法和应用
WO2023041049A1 (zh) 作为sos1抑制剂的杂环化合物及其用途
WO2024102952A1 (en) Sos1 inhibitors
CN110023315B (zh) 新的化合物或其药理学上可接受的盐
JP5134548B2 (ja) 過剰増殖性疾患の処置のためのErbBI型受容体チロシンキナーゼ阻害剤としてのN4−フェニルキナゾリン−4−アミン誘導体および関連化合物
JP2024532735A (ja) 複素環式化合物及び使用方法
WO2020253862A1 (zh) 含氮芳基磷氧化物类衍生物、其制备方法和应用
CN112442050A (zh) 一种ret抑制剂、其药物组合物及其用途
KR20210099611A (ko) 헤테로 방향족 유도체 조절제, 이의 제조방법 및 용도
CN117486888B (zh) 三环类化合物及其用途
AU2014262326B2 (en) [1,2,4] triazol [4,3-a] pyridine derivate, preparation method therefor or medical application thereof
CN105732637B (zh) 杂芳化合物及其在药物中的应用
CN112778311A (zh) 含氮并环类衍生物抑制剂、其制备方法和应用
CN112574236A (zh) 一种ret抑制剂、其药物组合物及其用途
WO2025230878A1 (en) Macrocyclic compounds as modulators of kras and uses thereof
WO2025230862A1 (en) Macrocyclic amino compounds as modulators of kras and uses therof
EP4419529A1 (en) Covalent egfr inhibitors and methods of use thereof
KR102607051B1 (ko) 헤테로아릴 유도체 화합물 및 이의 용도
KR20220090443A (ko) 헤테로아릴 유도체 화합물 및 이의 용도
CN119325471A (zh) Egfr抑制剂
HK40108597A (en) Heteroaryl derivative compound and use thereof
HK40087825A (en) Heteroaryl derivative compound and use thereof
RU2780532C1 (ru) Ингибиторы протеинтирозинфосфатазы